Overview
Mark Ahlman is a Nuclear Medicine provider practicing medicine in Augusta, Georgia. He has been practicing medicine for over 18 years.
Dr. Ahlman is highly rated in 1 condition, according to our data. His clinical expertise encompasses Erdheim-Chester Disease, Mediastinal Tumor, Primary Mediastinal B-Cell Lymphoma (PMBCL), and Acute Lymphoblastic Leukemia (ALL).
He is actively involved in clinical research, co-authoring 90 peer reviewed articles.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
1120 15th St, Augusta, GA 30912
1215 Lee St, Charlottesville, VA 22908
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Wellstar MCG Health
Natalie Shahbazi is a Nuclear Medicine provider practicing medicine in Augusta, Georgia. She has been practicing medicine for over 17 years. Her clinical expertise encompasses SVC Obstruction.
Frequently Asked Questions about Dr. Mark Ahlman
How do I make an appointment with Dr. Mark Ahlman?
You can book an appointment with Dr. Mark Ahlman by calling their office at 706-721-8623. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Ahlman a top-rated expert for Erdheim-Chester Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Ahlman is classified as an Advanced expert for Erdheim-Chester Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Ahlman specialize in?
While Dr. Mark Ahlman is a Nuclear Medicine, they have specific expertise in Erdheim-Chester Disease, Mediastinal Tumor, and Primary Mediastinal B-Cell Lymphoma (PMBCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nuclear Medicine.
Does Dr. Mark Ahlman participate in research or clinical trials?
Yes. Dr. Mark Ahlman has published 90 articles and abstracts on conditions like Erdheim-Chester Disease. You can view a list of Dr. Mark Ahlman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Ahlman accept my insurance?
Dr. Mark Ahlman accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 706-721-8623 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Erdheim-Chester DiseaseDr. Ahlman isAdvanced. Learn about Erdheim-Chester Disease.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ahlman isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Classical Hodgkin LymphomaDr. Ahlman isExperienced. Learn about Classical Hodgkin Lymphoma.
- HeadacheDr. Ahlman isExperienced. Learn about Headache.
- Lung NodulesDr. Ahlman isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Ahlman isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mediastinal TumorDr. Ahlman isExperienced. Learn about Mediastinal Tumor.